Brief: Shenzhen Hepalink Pharmaceutical Says Unit's "Enoxaparin Sodium Injection" Obtains U.S. FDA Approval

Shenzhen Hepalink Pharmaceutical Co

21/09/2020 16:25

Sept 21 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd  002399.SZ :
    * U.S. FDA APPROVED UNITS REGISTRATION AS SUPPLIER OF FINISH
DOSE
MEDICINES & ACTIVE PHARMACEUTICAL INGREDIENTS
    * UNIT'S REGISTRATION APPROVED AS SUPPLIER TO LICENSE HOLDER
FOR
ENOXAPARIN SODIUM INJECTION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS1v987N
Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))